You are viewing an old version of this page. View the current version.

Compare with Current View Page History

« Previous Version 4 Next »


Scope

This project is to evolve the Nonclinical Study Data Reviewer's Guide (nSDRG), based on comments from a public PHUSE review, plus to adapt it to updates of the FDA Technical Conformance Guide. The project continues to check and align with the SDRG template and guide developed by the Optimizing the Use of Data Standards Working Group for clinical studies.

Preparation of a Study Data Reviewer’s Guide (SDRG) is recommended as an integral part of a CDISC standards-compliant study data submission. The challenge is to operationalise this new documentation requirement efficiently and effectively.
Challenges we seek to answer with this project:

  • Provide a practical template for easy access and use

  • Provide guidance document which describes expected content and options to guide nonclinical SDRG authors.

  • Provide authors with examples, describing how to handle different data situations with SDRG content.

Things we expect to learn along the way:

  • Exploration of ways to generate the nonclinical SDRG and who should do the job.

  • The SDRG is expected to be useful by FDA reviewers. Can it also be useful for other nonclinical study stakeholders?

  • Will the SDRG evolve as systems and processes gain expertise in the new SEND requirements for submission of nonclinical data?

Project Leads

Email

Sue Dehaven
susan.dehaven@sanofi.com
Debra Oetzman
debra.oetzman@instem.com

Key Milestones 

ObjectiveTimeline
Prioritised list of domains/variables required for harmonisationQ3 2020 
Develop harmonisation recommendations for selected domains/variables and create white paper(s) for specific domains/variables as neededQ2 2021
Poster presentation and update of current working group progress at CSSQ2 2021 
PHUSE Publication or white paperQ2 2021

CURRENT STATUS

Project Members 

Organisation 
Anja MetzgerBayer

Brett Coupland

Astrazeneca

Cathy Roy

Merck

Christy Kubin 

MPI Research

Daniel Potenta 

PDS Lifesciences

Debra Oetzman

Instem

Deepika V.G 

Point Cross
Florence Halbert Novartis
Gitte Frausing Data Standards Decisions
Hepei Chen FDA
Jack Baker Covance
Jennifer Abbott Abbvie
Jennifer Feldmann Epreda
Karen Porter Point Cross
Kenneth Hershman Novartis

Project Members 

Organisation 

Linda Hunt 

Merck

Lindsy Eickhoff 

Basinc

Mandie Rhodes 

BMS

Mark Carfagna 

Eli Lilly
Matthew WhittakerFDA
Maureen Rossi Roche
Michael Rosentreter Bayer
Nicola Robertson GSK
Patricia Brundage FDA
Paul Brown FDA
Rick Thompson J&J
Senthil Palani Xybion
Steve PolleyGSK
Susie Lendal Antvorskov Data Standards Decisions
Tania Smith Covance
William Houser BMS


  • No labels